147 related articles for article (PubMed ID: 19048345)
1. Molecular imaging of phosphorylation events for drug development.
Chan CT; Paulmurugan R; Reeves RE; Solow-Cordero D; Gambhir SS
Mol Imaging Biol; 2009; 11(3):144-58. PubMed ID: 19048345
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth Kinetics.
Suchowski K; Pöschinger T; Rehemtulla A; Stürzl M; Scheuer W
Neoplasia; 2017 Apr; 19(4):310-320. PubMed ID: 28285180
[TBL] [Abstract][Full Text] [Related]
4. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
[TBL] [Abstract][Full Text] [Related]
5. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
Kondapaka SB; Singh SS; Dasmahapatra GP; Sausville EA; Roy KK
Mol Cancer Ther; 2003 Nov; 2(11):1093-103. PubMed ID: 14617782
[TBL] [Abstract][Full Text] [Related]
6. Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway.
Maiti D; Bhattacharyya A; Basu J
J Biol Chem; 2001 Jan; 276(1):329-33. PubMed ID: 11020382
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.
Yu HP; Hsieh YC; Suzuki T; Choudhry MA; Schwacha MG; Bland KI; Chaudry IH
J Leukoc Biol; 2007 Sep; 82(3):774-80. PubMed ID: 17586659
[TBL] [Abstract][Full Text] [Related]
9. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
Liang K; Jin W; Knuefermann C; Schmidt M; Mills GB; Ang KK; Milas L; Fan Z
Mol Cancer Ther; 2003 Apr; 2(4):353-60. PubMed ID: 12700279
[TBL] [Abstract][Full Text] [Related]
10. Silica induces cell cycle changes through PI-3K/AP-1 pathway in human embryo lung fibroblast cells.
Jia X; Liu B; Ye M; Liu H; Shi X
Cell Biochem Funct; 2010 Oct; 28(7):613-9. PubMed ID: 20941752
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of homodimeric protein-protein interactions in living subjects.
Massoud TF; Paulmurugan R; Gambhir SS
FASEB J; 2004 Jul; 18(10):1105-7. PubMed ID: 15132989
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
13. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.
Furet P; Guagnano V; Fairhurst RA; Imbach-Weese P; Bruce I; Knapp M; Fritsch C; Blasco F; Blanz J; Aichholz R; Hamon J; Fabbro D; Caravatti G
Bioorg Med Chem Lett; 2013 Jul; 23(13):3741-8. PubMed ID: 23726034
[TBL] [Abstract][Full Text] [Related]
14. LY294002, an inhibitor of PI-3K, enhances heat sensitivity independently of p53 status in human lung cancer cells.
Ohnishi K; Yasumoto J; Takahashi A; Ohnishi T
Int J Oncol; 2006 Jul; 29(1):249-53. PubMed ID: 16773206
[TBL] [Abstract][Full Text] [Related]
15. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
16. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
[TBL] [Abstract][Full Text] [Related]
18. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
Kakazu A; Chandrasekher G; Bazan HE
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053
[TBL] [Abstract][Full Text] [Related]
19. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.
Wang X; Yue P; Kim YA; Fu H; Khuri FR; Sun SY
Cancer Res; 2008 Sep; 68(18):7409-18. PubMed ID: 18794129
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts.
Takai S; Tokuda H; Matsushima-Nishiwaki R; Hanai Y; Kato K; Kozawa O
J Cell Biochem; 2006 Aug; 98(5):1249-56. PubMed ID: 16514645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
